Certain patient groups may be underrepresented or excluded from RCTs due to eligibility criteria, logistical barriers, ethical concerns or other reasons.
Examples of these potential groups are females, pregnant or breastfeeding females, older adults due to age or comorbidities, children, people […]
ATHAGORAS Holding GmbH is building a group of leading service providers to create a tech-enabled European specialist service provider for the clinical and commercial development of healthcare innovations in the pharmaceutical & biotech industry within regulatory affairs, pharmacovigilance, as […]
Quantify Research‘s very own Mary Rosenzweig will join speakers from Monsenso, Lundbeck and […]
The Quantify Research team are back and ready to get into in the swing of things following our Christmas break.
With fresh New Years Resolutions at the ready we look forward to catching up with […]
For the second year running, the Nordic team got together in Stockholm this week to eat a traditional Julbord – a smorgasbord of wintery delicacies at Gamla Riksarkivet.
The cherry on top was the entire […]
On December 13th every year the Quantify Research team celebrate Saint Lucia by candlelit procession, Christmas carols and saffron buns.
As we approach the darkest time of the year in Scandinavia we really need all […]
Since 2020, Quantify Research has been a proud partner to the European Medicines Agency-coordinated ENCePP (European Network for Centers of Pharmacoepidemiology and Pharmacovigilance) initiative.
This network brings together expertise […]
We often highlight our employees talent when it comes to research but did you know that there are some real artistic creativity in our team?
At our Bob Ross painting session last week we discovered multiple talented artists within our team […]
𝐌𝐀𝐒𝐋𝐃/𝐌𝐀𝐒𝐇: 𝐂𝐥𝐢𝐧𝐢𝐜𝐚𝐥 𝐚𝐧𝐝 𝐄𝐜𝐨𝐧𝐨𝐦𝐢𝐜 𝐅𝐢𝐧𝐝𝐢𝐧𝐠𝐬 𝐟𝐫𝐨𝐦 40-𝐲𝐞𝐚𝐫 𝐅𝐨𝐥𝐥𝐨𝐰-𝐔𝐩 𝐃𝐚𝐭𝐚
On Tuesday December 10th, Quantify’s Emilie Toresson Grip is one of three speakers at ISPOR’s webinar on MASLD/ MASH following their BRIDGE-MASH study.
Moderated by Riku Ota, Global Payer Evidence Lead at […]
Real-world evidence derived from data collected in routine clinical care is increasingly important for decision-makers in payer and regulatory environments.
Nordic health data has several characteristics that enable a globally unique research environment […]